CRBP earnings call for the period ending September 30, 2020.
News & Analysis: Corbus Pharmaceuticals Holdings
A late-stage clinical failure is weighing heavily on the biotech's stock today.
These cheap companies have upcoming binary catalysts for explosive growth.
Pharmaceutical stocks are popular with Robinhood Investors, including three I would stay away from and one that I wouldn't.
Could the most popular biotech stocks on Robinhood be the biggest winners for other investors?
These have the highest analyst ratings among Robinhood's 100 most popular stocks.
These pharmaceutical giants are already preparing for the possibility of medical marijuana legalization.
Two biotechs have big risks, one is a buy, and the other is a big opportunity to consider.
CRBP earnings call for the period ending June 30, 2020.
Each of these three stocks are on Robinhood’s top 100 most-held list.